相关实验视频

Updated: Jun 16, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

小说MED15::ATF1融合在一个小儿黑色素瘤与spitzoid特征和侵略性的呈现

Larissa V Furtado¹, Maria Cardenas², Teresa Santiago¹

¹Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Genes, chromosomes & cancer

|March 9, 2024

概括

一个罕见的儿科黑色素瘤病例揭示了一种新的MED15::ATF1基因融合. 这一发现有助于了解具有状特征的侵袭性儿童黑色素瘤的分子基础.

科学领域:

儿科瘤学儿科瘤学
分子病理学分子病理学
皮肤病学皮肤病学

背景情况:

儿童黑色素瘤是一种罕见的儿科癌症,具有多种细胞类型.
诊断儿科黑色素瘤包括将其与其他线或上皮细胞瘤区分开来.
黑色素瘤中已知的分子变化包括MAPK,PI3K/AKT/mTOR通路,瘤抑制剂和端粒酶.

研究的目的:

为了确定特定的儿科黑色素瘤病例的分子基础.
为了描述小儿黑色素瘤中的新型遗传变异.

主要方法:

一个儿科黑色素瘤患者的病例报告.
分子分析以确定基因融合.

主要成果:

发现了一种新的MED15::ATF1基因融合.
确定的融合存在于一个小儿黑色素瘤与spitzoid形态.
这位患者的黑色素瘤呈现出积极的临床过程.

结论:

MED15::ATF1融合代表了儿童黑色素瘤中新发现的分子变异.
这种融合可能在侵袭性spitzoid儿科黑色素瘤的发病过程中发挥作用.

关键词:

在ATF1中使用ATF1.在MED15中,MED15是MED15的版本.媒体15:ATF1融合儿科的黑色素瘤这是一个spitzoid.整个转录基因组的测序.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

相关概念视频

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...